These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16412238)

  • 1. Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3).
    Francis GA; Li G; Casey R; Wang J; Cao H; Leff T; Hegele RA
    BMC Med Genet; 2006 Jan; 7():3. PubMed ID: 16412238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-base mutation in the peroxisome proliferator-activated receptor gamma4 promoter associated with altered in vitro expression and partial lipodystrophy.
    Al-Shali K; Cao H; Knoers N; Hermus AR; Tack CJ; Hegele RA
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5655-60. PubMed ID: 15531525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma.
    Monajemi H; Zhang L; Li G; Jeninga EH; Cao H; Maas M; Brouwer CB; Kalkhoven E; Stroes E; Hegele RA; Leff T
    J Clin Endocrinol Metab; 2007 May; 92(5):1606-12. PubMed ID: 17299075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophy.
    Lüdtke A; Buettner J; Wu W; Muchir A; Schroeter A; Zinn-Justin S; Spuler S; Schmidt HH; Worman HJ
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2248-55. PubMed ID: 17356052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
    Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A LMNA splicing mutation in two sisters with severe Dunnigan-type familial partial lipodystrophy type 2.
    Morel CF; Thomas MA; Cao H; O'Neil CH; Pickering JG; Foulkes WD; Hegele RA
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2689-95. PubMed ID: 16636128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3.
    Miehle K; Porrmann J; Mitter D; Stumvoll M; Glaser C; Fasshauer M; Hoffmann K
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):141-8. PubMed ID: 26119484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.
    Jeninga EH; van Beekum O; van Dijk AD; Hamers N; Hendriks-Stegeman BI; Bonvin AM; Berger R; Kalkhoven E
    Mol Endocrinol; 2007 May; 21(5):1049-65. PubMed ID: 17312272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand.
    Lüdtke A; Buettner J; Schmidt HH; Worman HJ
    J Med Genet; 2007 Sep; 44(9):e88. PubMed ID: 17766367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating exosomal circRNA-miRNA-mRNA network in a familial partial lipodystrophy type 3 family with a novel
    Zhou L; Li S; Ren J; Wang D; Yu R; Zhao Y; Zhang Q; Xiao X
    Am J Physiol Endocrinol Metab; 2024 Sep; 327(3):E357-E370. PubMed ID: 39017680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from human mutations in PPARgamma.
    Hegele RA
    Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S31-5. PubMed ID: 15711581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel loss of function Ile354Val mutation in PPARG causes familial partial lipodystrophy.
    Padova G; Prudente S; Vinciguerra F; Sudano D; Baratta R; Bellacchio E; Trischitta V; Vallone A; Sciacca L; Frittitta L
    Acta Diabetol; 2020 May; 57(5):589-596. PubMed ID: 31863320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy.
    Agarwal AK; Garg A
    J Clin Endocrinol Metab; 2002 Jan; 87(1):408-11. PubMed ID: 11788685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations.
    Demir T; Onay H; Savage DB; Temeloglu E; Uzum AK; Kadioglu P; Altay C; Ozen S; Demir L; Cavdar U; Akinci B
    Diabet Med; 2016 Oct; 33(10):1445-50. PubMed ID: 26756202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.
    Hegele RA; Cao H; Frankowski C; Mathews ST; Leff T
    Diabetes; 2002 Dec; 51(12):3586-90. PubMed ID: 12453919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: A New Peroxisome Proliferator-Activated Receptor Gamma Mutation Causes Familial Partial Lipodystrophy Type 3 in a Chinese Patient.
    Chen X; Ma Z; Chen P; Song X; Li W; Yu X; Xie J
    Front Endocrinol (Lausanne); 2022; 13():830708. PubMed ID: 35422762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diseases of adipose tissue: genetic and acquired lipodystrophies.
    Capeau J; Magré J; Lascols O; Caron M; Béréziat V; Vigouroux C; Bastard JP
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1073-7. PubMed ID: 16246048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A complicated pregnancy in a patient with lipodystrophic diabetes attributable to a peroxisome proliferator-activated receptor gamma (PPARG) mutation.
    Madhra M; Noh RM; Zammitt NN; Patrick AW; Love CD
    Diabet Med; 2012 Oct; 29(10):e398-401. PubMed ID: 22803842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A frameshift mutation in peroxisome-proliferator-activated receptor-gamma in familial partial lipodystrophy subtype 3 (FPLD3; MIM 604367).
    Hegele RA; Ur E; Ransom TP; Cao H
    Clin Genet; 2006 Oct; 70(4):360-2. PubMed ID: 16965332
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial partial lipodystrophy resulting from loss-of-function PPARγ pathogenic variants: phenotypic, clinical, and genetic features.
    Soares RMV; da Silva MA; Campos JTAM; Lima JG
    Front Endocrinol (Lausanne); 2024; 15():1394102. PubMed ID: 39398333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.